13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001279151
Total reported value
$146.3M
$146.3M
22 檔
50.7%
According to the latest 13F quarterly dataset, Luminus Management LLC managed an equity portfolio of $146.3M at the end of Q4 2025, spanning 22 distinct U.S. exchange-listed positions.
In Q4 2025, Luminus Management LLC displayed an active expansion posture, initiating 11 new positions and adding to 6 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | OI | O-i Glass Inc | Stock-Other | 20.33% | -5.60% | -23.09% | |
| 2 | VG | Venture Global Inc-cl A | Stock-Energy | 16.12% | — | — | |
| 3 | SDA | Sealed Air CORP | Stock-Consumer Disc | 13.02% | -7.41% | EXIT | |
| 4 | KWR | Quaker Chemical Corporation | Stock-Other | 9.32% | -1.73% | +28.22% | |
| 5 | BATL | Battalion Oil CORP | Stock-Other | 6.09% | -3.77% | — | |
| 6 | AXTA | Axalta Coating Systems Ltd. | Stock-Materials | 5.62% | -6.68% | EXIT | |
| 7 | AVNT | Avient CORP | Stock-Materials | 5.41% | +7.65% | +326.12% | |
| 8 | ✓ | Venture Global Inc | Stock-Other | 5.08% | — | — | |
| 9 | GXO | Gxo Logistics Inc | Stock-Industrials | 4.99% | +7.09% | +87.30% | |
| 10 | SOLS | Solstice Adv Materials Inc | Stock-Materials | 4.17% | +1.42% | — | |
| 11 | CC | Chemours Co/the | Stock-Materials | 3.70% | -1.49% | -79.71% | |
| 12 | WLK | Westlake CORP | Stock-Materials | 2.28% | — | — | |
| 13 | VXX | Ipath Series B S&p 500 Vix | ETF-Large Cap & Growth | 1.27% | +0.58% | +30.95% | |
| 14 | ACET | Adicet Bio Inc | Stock-Other | 0.44% | — | — | |
| 15 | SGMOQ | Sangamo Therapeutics Inc | Stock-Other | 0.43% | -0.25% | EXIT | |
| 16 | DHX | Dhi Group Inc | Stock-Other | 0.36% | — | — | |
| 17 | LUCD | Lucid Diagnostics Inc | Stock-Other | 0.35% | — | -59.36% | |
| 18 | MXCT | Maxcyte Inc | Stock-Other | 0.32% | -0.44% | +5.11% | |
| 19 | FRMI | Fermi Inc | Stock-Other | 0.28% | +0.10% | NEW | |
| 20 | VTGN | Vistagen Therapeutics Inc | Stock-Other | 0.20% | -0.08% | — | |
| 21 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.14% | — | — | |
| 22 | CRCL | Circle Internet Group Inc | Stock-Financials | 0.07% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VG | Venture Global Inc-cl A | +16.1% | NEW | New buy |
| 2 | AVNT | Avient CORP | +4% | +326.12% | Add |
| 3 | GXO | Gxo Logistics Inc | +2.2% | +87.30% | Add |
| 4 | KWR | Quaker Chemical Corporation | +2.2% | +28.22% | Add |
| 5 | SGMOQ | Sangamo Therapeutics Inc | +0.3% | +363.50% | Add |
| 6 | VXX | Ipath Series B S&p 500 Vix | 0% | +30.95% | Add |
| 7 | MXCT | Maxcyte Inc | — | +5.11% | Add |
| 8 | LUCD | Lucid Diagnostics Inc | -0.5% | -59.36% | Trim |
| 9 | BATL | Battalion Oil CORP | -0.6% | — | Unchanged |
| 10 | SDA | Sealed Air CORP | -2.8% | -28.08% | Trim |
| 11 | OI | O-i Glass Inc | -3.5% | -23.09% | Trim |
| 12 | CC | Chemours Co/the | -21.4% | -79.71% | Trim |
| 13 | KEX | Kirby CORP | — | EXIT | Sold out |
| 14 | AXTA | Axalta Coating Systems Ltd. | — | NEW | New buy |
| 15 | ✓ | Venture Global Inc | — | NEW | New buy |
| 16 | SOLS | Solstice Adv Materials Inc | — | NEW | New buy |
| 17 | WLK | Westlake CORP | — | NEW | New buy |
| 18 | FUL | H.b. Fuller Co. | — | EXIT | Sold out |
| 19 | SOC | Sable Offshore CORP | — | EXIT | Sold out |
| 20 | DQ | Daqo New Energy Corp-adr | — | EXIT | Sold out |
| 21 | ACET | Adicet Bio Inc | — | NEW | New buy |
| 22 | REKR | Rekor Systems Inc | — | EXIT | Sold out |
| 23 | DHX | Dhi Group Inc | — | NEW | New buy |
| 24 | ✓ | Mersana Therapeutics Inc | — | EXIT | Sold out |
| 25 | ✓ | Fibrobiologics Inc | — | EXIT | Sold out |
| 26 | ✓ | Stardust Pwr Inc | — | EXIT | Sold out |
| 27 | FRMI | Fermi Inc | — | NEW | New buy |
| 28 | VTGN | Vistagen Therapeutics Inc | — | NEW | New buy |
| 29 | MREO | Mereo Biopharma Group Pl-adr | — | NEW | New buy |
| 30 | CRCL | Circle Internet Group Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Luminus Management LLC reported a total U.S. public equity portfolio value of $146.3M across 22 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including OI, VG, SDA) accounted for 50.7% of total reported equity market value during Q4 2025.
Top New Position Initiated
VG
市值: $18.4M
Top Position Liquidated / Trimmed
KEX
前期市值: $9.8M
During Q4 2025, Luminus Management LLC's top holdings by market value included OI (20.3%)、VG (16.1%)、SDA (13.0%). The largest single position, OI, represented 20.3% of total portfolio value.
In Q4 2025, Luminus Management LLC made 29 total portfolio adjustments, initiating 11 new buys, adding to 6 positions, trimming 4 holdings, and fully liquidating 8 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.